🇺🇸 FDA
Patent

US 11999747

Furoquinolinediones as inhibitors of TDP2

granted A61KA61K31/122A61K31/136

Quick answer

US patent 11999747 (Furoquinolinediones as inhibitors of TDP2) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Jun 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/122, A61K31/136, A61K31/194, A61K31/343